Simpson Thacher & Bartlett LLP

Private Equity: Buyouts & Venture Capital Investment (International Firms) Department

China
Current View:

This content is provided by Chambers. Learn more about our methodology

What the team is known for Skilled transactional practice acknowledged for its strength in major private equity acquisitions and investments. Particularly active on substantial cross-border and regional deals in the TMT, fintech and pharmaceutical sectors. Notable for its strong working relationship with leading private equity houses, and continues to increase its global client base. Well suited to advise on deals involving both the USA and Greater China, leveraging its highly regarded private equity teams throughout the USA. Also active on deals that include assets in India, Singapore, Indonesia and Japan.

Strengths The practice is held in high acclaim by a market source for its "good private equity pedigree."

Work highlights Acted for KKR on its acquisition of certain international operations, valued at approximately USD2.2 billion, from Campbell Soup Company.

Notable practitioners


Ian Ho
is described by one interviewee as a "great execution guy" for his handling of cross-border acquisitions and investments. He is routinely instructed by high-profile investors and fund-raising entities alike.


Yang Wang
remains a popular choice of adviser for international and Chinese investors and private equity firms, and receives praise for his "technically sound" approach. His recent work includes advising on a variety of investments in the life sciences and TMT sectors, among others.